{
    "Trade/Device Name(s)": [
        "Triage CardioProfilER Panel",
        "Triage Profiler S.O.B. Panel"
    ],
    "Submitter Information": "Biosite Incorporated",
    "510(k) Number": "K080269",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051787"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBC",
        "JHX",
        "DDR",
        "MMI",
        "DAP"
    ],
    "Summary Letter Date": "June 6, 2008",
    "Summary Letter Received Date": "March 19, 2008",
    "Submission Date": "January 31, 2008",
    "Regulation Number(s)": [
        "21CFR862.1117",
        "21CFR862.1215",
        "21CFR866.5680",
        "21CFR864.7320"
    ],
    "Regulation Name(s)": [
        "B-type natriuretic peptide test system",
        "Fluorometric Method, CPK or Isoenzymes",
        "Myoglobin, Antigen, Antiserum, Control",
        "Immunoassay Method, Troponin Subunit",
        "Fibrinogen/Fibrin Degradation Products Assay"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "coagulation"
    ],
    "Analyte(s)": [
        "Creatine Kinase MB",
        "Myoglobin",
        "Troponin I",
        "B-type natriuretic peptide",
        "D-dimer"
    ],
    "Specimen Type(s)": [
        "Whole blood",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Triage Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescence immunoassay"
    ],
    "Methodologies": [
        "Quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Panel",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Biosite Triage CardioProfilER and Profiler S.O.B. Panels for quantitative determination of cardiac and coagulation biomarkers using fluorescence immunoassay with Triage Meter.",
    "Indications for Use Summary": "Aid in diagnosis and assessment of myocardial infarction, heart failure, risk stratification of heart failure and acute coronary syndromes; Profiler S.O.B. Panel also aids in assessment of suspected disseminated intravascular coagulation and thromboembolic events, including pulmonary embolism.",
    "fda_folder": "Clinical Chemistry"
}